Results
67
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
67 companies
Strategy
Market Cap: US$92.4b
Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.
MSTR
US$300.70
7D
-13.9%
1Y
81.2%
Market Cap: US$44.1b
Operates a digital community in the United States and internationally.
RDDT
US$232.75
7D
-14.0%
1Y
249.9%
Carlyle Group
Market Cap: US$23.1b
An investment firm specializing in direct and fund of fund investments.
CG
US$63.65
7D
-8.2%
1Y
48.7%
Amer Sports
Market Cap: US$18.9b
Designs, manufactures, markets, distributes, and sells sports equipment, apparel, footwear, and accessories in Europe, the Middle East, Africa, the Americas, Mainland China, Hong Kong, Macau, Taiwan, and the Asia Pacific.
AS
US$34.28
7D
-9.5%
1Y
115.9%
Bloom Energy
Market Cap: US$16.2b
Designs, manufactures, sells, and installs solid-oxide fuel cell systems for on-site power generation in the United States and internationally.
BE
US$68.69
7D
-15.2%
1Y
559.8%
BridgeBio Pharma
Market Cap: US$9.7b
A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.
BBIO
US$49.00
7D
-8.1%
1Y
100.2%
MINISO Group Holding
Market Cap: US$7.1b
An investment holding company, engages in the retail and wholesale of design-led lifestyle and pop toy products in China, the rest of Asia, the Americas, Europe, Indonesia, and internationally.
MNSO
US$22.29
7D
-10.0%
1Y
44.5%
PTC Therapeutics
Market Cap: US$4.7b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$57.84
7D
-8.0%
1Y
53.6%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.21
7D
-14.3%
1Y
37.0%
GeneDx Holdings
Market Cap: US$3.3b
A genomics company, provides genetic testing services.
WGS
US$112.96
7D
-13.6%
1Y
178.1%
Pagaya Technologies
Market Cap: US$2.7b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.
PGY
US$34.78
7D
-20.6%
1Y
260.4%
Worthington Enterprises
Market Cap: US$2.7b
Operates as an industrial manufacturing company.
WOR
US$52.79
7D
-15.9%
1Y
31.7%
Brookfield Business
Market Cap: US$2.5b
Owns and operates services and industrials operations in the United States, Australia, Brazil, the United Kingdom, and internationally.
BBUC
US$32.95
7D
-8.6%
1Y
31.0%
Chefs' Warehouse
Market Cap: US$2.4b
Distributes specialty food and center-of-the-plate products in the United States, the Middle East, and Canada.
CHEF
US$59.64
7D
-10.6%
1Y
39.7%
Wolverine World Wide
Market Cap: US$2.3b
Designs, manufactures, sources, markets, licenses, and distributes footwear, apparel, and accessories in the United States, Europe, the Middle East, Africa, the Asia Pacific, Canada and Latin America.
WWW
US$27.91
7D
-8.2%
1Y
62.5%
Liquidia
Market Cap: US$1.9b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$22.45
7D
-9.0%
1Y
121.4%
Ouster
Market Cap: US$1.7b
Provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
OUST
US$28.67
7D
-17.4%
1Y
355.8%
IDT
Market Cap: US$1.6b
Provides communications and payment services in the United States, the United Kingdom, and internationally.
IDT
US$61.75
7D
-9.1%
1Y
61.2%
Willdan Group
Market Cap: US$1.4b
Provides professional, technical, and consulting services primarily in the United States.
WLDN
US$97.11
7D
-8.2%
1Y
138.1%
Precigen
Market Cap: US$1.2b
A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
PGEN
US$3.49
7D
-8.3%
1Y
282.0%
ThredUp
Market Cap: US$1.1b
Operates an online resale platform in the United States.
TDUP
US$9.31
7D
-12.7%
1Y
999.2%
Atlanticus Holdings
Market Cap: US$1.0b
A financial technology company, provides products and services to lenders in the United States.
ATLC
US$64.53
7D
-9.7%
1Y
89.5%
Northeast Bank
Market Cap: US$922.9m
Provides various banking services to individual and corporate customers in Maine.
NBN
US$103.18
7D
-8.6%
1Y
33.4%
Oil-Dri Corporation of America
Market Cap: US$909.5m
Develops, manufactures, and markets sorbent products in the United States and internationally.
ODC
US$62.73
7D
-9.0%
1Y
83.6%
Claritev
Market Cap: US$867.6m
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
CTEV
US$49.85
7D
-10.0%
1Y
533.4%
Yatsen Holding
Market Cap: US$845.6m
Engages in the development and sale of beauty products in the People’s Republic of China.
YSG
US$8.90
7D
-12.0%
1Y
155.0%
UroGen Pharma
Market Cap: US$832.3m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$17.26
7D
-8.5%
1Y
35.4%
Allient
Market Cap: US$753.6m
Designs, manufactures, and sells precision and specialty-controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and the Asia-Pacific.
ALNT
US$43.64
7D
-8.7%
1Y
128.1%
Akebia Therapeutics
Market Cap: US$734.5m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$2.71
7D
-8.4%
1Y
103.8%
Gossamer Bio
Market Cap: US$679.9m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$2.78
7D
-9.7%
1Y
192.0%
Domo
Market Cap: US$675.4m
Operates a cloud-based modern AI and data products platform in North America, Western Europe, Australia, Japan, and India.
DOMO
US$16.16
7D
-9.0%
1Y
131.9%
Stitch Fix
Market Cap: US$614.6m
Sells a range of apparel, shoes, and accessories for women’s, petite, maternity, men’s, plus, and kids through its website and mobile application in the United States.
SFIX
US$4.71
7D
-17.5%
1Y
86.2%
Finance of America Companies
Market Cap: US$574.9m
A financial service holding company, through its subsidiaries, provides home equity-based financing solutions for a modern retirement in the United States.
FOA
US$22.93
7D
-11.2%
1Y
120.1%
Rigel Pharmaceuticals
Market Cap: US$543.1m
A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.
RIGL
US$28.70
7D
-18.3%
1Y
79.4%
Verastem
Market Cap: US$529.9m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$8.61
7D
-9.7%
1Y
229.9%
American Oncology Network
Market Cap: US$482.3m
Through its subsidiaries, provides oncology management services in the United States.
AONC
US$9.60
7D
-9.3%
1Y
140.0%